Get Adobe Flash player

PO Box 1604
Kitty Hawk, NC 27949


866.935.STAT (7828)

866.276.STAT (7828)

[email protected]

Privacy Data Shield Policy

News Event and Announcement Detail

February 10, 2012

EmpiriStat Sponsors Leading TBI Conference

The 2nd Annual Traumatic Brain Injury Conference, “Challenges and Opportunities in Preclinical and Clinical Development of New Diagnostics and Therapeutics,” has been scheduled for March 6-7, 2012 in Washington, D.C. EmpiriStat, Inc., one of the industry’s leading partners for specialized biostatical consulting and programming, is proud to sponsor this important meeting dedicated to the development of new diagnostics and therapeutics for traumatic brain injury (TBI). 

Experts from academia, industry, the military and government will be highlighting strategies for clinical assessment of TBI and will address chronic outcomes of TBI, and will address chronic outcomes of TBI, including post-traumatic stress disorder and neurodegeneration.
The purpose of the conference is to address traumatic brain injury from a variety of perspectives in order to provide attendees with a holistic perspective on the diagnosis, treatment and outcomes associated with traumatic brain injury.
EmpiriStat, fresh from its work on TBI with the United States Army Medical Research and Materiel Command (USAMRMC) is dedicated to offering its expertise and insight on a subject so important for our nation’s fighting men and women.
Conference presenters will be addressing the following issues:
·         Advances in neuroimaging for TBI
·         Clinical trial design for new TBI therapeutics
·         Implementation of biomarkers for stratification, outcome prediction and therapeutics intervention monitoring
·         Pre-clinical modeling and translating results to the clinic
·         Drug delivery (blood-brain barrier) challenges facing development of new therapies
·         Treatment of actute as well as post-acute/chronic neurorehabilitation
·         Halting secondary injury in TBI
·         Cell therapy potential for TBI
·         Cognitive measures of TBI and outcomes
·         Neuroprotection as a therapeutic intervention
·         Regulatory perspectives on clinical trials and companion diagnostic development and commercialization
The EmpiriStat team is looking forward to attending this important conference and meeting new colleagues.   Please stop by their Exhibit booth to learn more about their research in TBI and how EmpiriStat can advance your TBI research.
For more information on the conference, please go to
For more information on the wide range of expertise offered by EmpiriStat, please go to or contact EmpiriStat directly at:
EmpiriStat, Inc.
13694 Sam Hill Drive
Mount Airy, MD 21771
Tel: 866.935.STAT (7828)
Fax: 866.276.STAT (7828)

Back to news...